Aura Biosciences (AURA) Cash & Current Investments (2020 - 2026)
Aura Biosciences (AURA) posted Cash & Current Investments of $84.8 million for Q1 2026, up 42.47% on a QoQ basis from $59.5 million in Q4 2025, and up 121.82% year-over-year from $38.2 million in Q1 2025.
Aura Biosciences (AURA) Cash & Current Investments (2020 - 2026) Analysis & Trends
Aura Biosciences' Cash & Current Investments history runs 7 years deep, the most recent figure standing at $84.8 million for Q1 2026.
- Quarterly Cash & Current Investments rose 121.82% year-over-year to $84.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $84.8 million (up 121.82% YoY) and the FY2025 annual result came in at $59.5 million, up 87.79% from the prior year.
- Cash & Current Investments was $84.8 million for Q1 2026 at Aura Biosciences, up from $59.5 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $107.4 million in Q2 2025 and bottomed at $20000.0 in Q4 2022.
- A 5-year average of $38.5 million and a median of $38.2 million in 2025 frame the typical range for Cash & Current Investments.
- Peak annual rise in Cash & Current Investments reached 305450.0% in 2022, while the deepest fall reached 99.99% in 2022.
- Aura Biosciences' Cash & Current Investments stood at $20000.0 in 2022, then soared by 205215.0% to $41.1 million in 2023, then slipped by 22.82% to $31.7 million in 2024, then soared by 87.79% to $59.5 million in 2025, then soared by 42.47% to $84.8 million in 2026.
- Business Quant data shows AURA's Cash & Current Investments at $84.8 million in Q1 2026, $59.5 million in Q4 2025, and $47.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,071.81 Bn | - | 283.54 Mn |
| 2 | Nanobiotix | 1,925.70 Bn | 1,925.64 Bn | - | 61.40 Mn |
| 3 | Akari Therapeutics | 1,062.88 Bn | 1,062.88 Bn | - | - |
| 4 | BeOne Medicines | 469.09 Bn | 464.29 Bn | 1.35 Bn | 4.79 Bn |
| 5 | Vertex Pharmaceuticals | 123.09 Bn | 115.84 Bn | 2.59 Bn | 7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 70.32 Bn | 61.57 Bn | 3.31 Bn | 8.75 Bn |
| 7 | Belite Bio | 63.36 Bn | 63.36 Bn | - | - |
| 8 | Argenx Se | 55.90 Bn | 50.71 Bn | 1.41 Bn | 5.18 Bn |
| 9 | Alnylam Pharmaceuticals | 37.69 Bn | 34.68 Bn | 959.66 Mn | 3.01 Bn |
| 10 | Aura Biosciences | 479.55 Mn | 394.76 Mn | - | 84.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 84.79 Mn |
| Dec 31, 2025 | 59.52 Mn |
| Sep 30, 2025 | 47.55 Mn |
| Jun 30, 2025 | 107.37 Mn |
| Mar 31, 2025 | 38.23 Mn |
| Dec 31, 2024 | 31.69 Mn |
| Sep 30, 2024 | 25.41 Mn |
| Jun 30, 2024 | 30.08 Mn |
| Mar 31, 2024 | 26.28 Mn |
| Dec 31, 2023 | 41.06 Mn |
| Sep 30, 2023 | 20,000.00 |
| Jun 30, 2023 | 47.73 Mn |
| Mar 31, 2023 | 20,000.00 |
| Dec 31, 2022 | 20,000.00 |
| Sep 30, 2022 | 61.11 Mn |
| Jun 30, 2022 | 53.85 Mn |
| Mar 31, 2022 | 23,000.00 |
| Dec 31, 2021 | 149.06 Mn |
| Sep 30, 2021 | 20,000.00 |
| Jun 30, 2021 | 92.20 Mn |